TrialSchizophrenia bulletin2011

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.

Andreas Bechdolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.